MIAMI, Oct. 1, 2015—Global Stem Cells Group, has announced the launch of a new stem cell treatment center in Cochabamba, Bolivia. The new facility will provide advanced protocols and state-of-the-art techniques in cellular medicine to patients from around the world.
The opening of the Cochabamba stem cell clinic is in association with aesthetic surgery specialist Katherine Antezana, and will provide adipose derived stem cell treatments for aesthetic and cosmetic procedures. Under the Global Stem Cells Group brand, the new clinic will initiate a study on the use of adipose stem cells for hair growth.
This latest clinic opening is part of GSCG’s continued expansion in the region.
Global Stem Cells Group has been expanding its clinical presence worldwide by partnering with qualified physicians experienced in stem cell therapies to open new clinics, licensed and developed under the GSCG banner.
Global Stem Cells Group provides stem cell treatments for a variety of diseases and conditions, including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes, and multiple sclerosis at various facilities worldwide. The new facility in Cochabamba will have an international staff that is experienced in administering the leading cellular therapies available.
Global Stem Cells Group’s Cochabamba, Bolivia clinic is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. GSCG clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.
The Global Stem Cells Group is committed to providing the highest of standards of services and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.
For more information, visit the Global Stem Cells Group website, email bnovas(at)stemcellsgroup(dot)com, or call +1 305 560 5337.
About the Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/